XML 41 R34.htm IDEA: XBRL DOCUMENT v3.24.3

Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Schedule Of Summary Of Significant Accounting Policies [Line Items]
Inventory	$ 121,058	$ 146,362
Regulatory Approval Granted US Food and Drug Administration [Member]
Schedule Of Summary Of Significant Accounting Policies [Line Items]
Inventory	$ 15,400	$ 19,400

X

- Definition

Schedule of summary of significant accounting policies.

+ References

No definition available.

+ Details

Name:	apls_ScheduleOfSummaryOfSignificantAccountingPoliciesLineItems
Namespace Prefix:	apls_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483467/210-10-45-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_InventoryNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Details

Name:	us-gaap_RegulatoryAgencyAxis=apls_FoodAndDrugAdministrationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: